Sonnet Biotherapeutics Holdings Inc (SONN) |
|
2.42 -0.19 (-7.28%)
|
02-25 12:22 |
|
Open: |
2.64 |
Pre. Close: |
2.61 |
|
High:
|
2.68 |
Low:
|
2.41 |
|
Volume:
|
1,916,617 |
Market Cap:
|
42M |
|
|
|
|
Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.664 - 2.679 |
2.679 - 2.692 |
|
Low:
|
2.511 - 2.53 |
2.53 - 2.548 |
|
Close:
|
2.582 - 2.61 |
2.61 - 2.636 |
|
Technical analysis |
as of: 2021-02-25 11:51:08 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 3.54 One year: 3.99 |
| Support: |
Support1: 2.40 Support2: 2.00 |
| Resistance: |
Resistance1: 3.03 Resistance2: 3.42 |
| Pivot: |
2.93  |
| Moving Average: |
MA(5): 2.67 MA(20): 2.88
MA(100): 2.63 MA(250): 4.20 |
| MACD: |
MACD(12,26): -0.01 Signal(9): 0.07 |
| Stochastic oscillator: |
%K(14,3): 14.38 %D(3): 20.89 |
| RSI: |
RSI(14): 36.12 |
| 52-week: |
High: 54.60 Low: 2.20 Change(%): -75.8 |
| Average Vol(K): |
3-Month: 111269 10-Days: 143726 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.SONN has closed below the lower band by 2.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 76.9% wider than normal. The large width of the bands suggest high volatility as compared to SONN's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 18 Feb 2021
Where Will Chanticleer Holdings Common Stock (SONN) Stock Go Next After It Is Down 5.88% in a Week? - InvestorsObserver
Tue, 16 Feb 2021
Sonnet BioTherapeutics Provides Fiscal Year 2021 First Quarter Business and Earnings Update - BioSpace
Wed, 03 Feb 2021
How Will the Market React to Chanticleer Holdings Common Stock (SONN) Stock Getting a Bullish Rating - InvestorsObserver
Mon, 01 Feb 2021
Sonnet BioTherapeutics Completes Successful Repeat Dose Study of SON-1010 in Non-Human Primates - StreetInsider.com
Mon, 25 Jan 2021
Sonnet BioTherapeutics Announces the Successful Completion of a Non-human Primate Toxicology Study of SON-080 - Yahoo Finance
Thu, 17 Dec 2020
Sonnet BioTherapeutics Provides Fiscal Year 2020 Business and Earnings Update - Yahoo Finance
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Underperform |
|
